If you have been reading about GIP receptor and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Last reviewed on 2025-08-18. Where a claim depends on a specific study, the study is described rather than over-claimed.
In clinical research, tirzepatide has been studied in randomized controlled trials for glycemic control and body weight reduction. These trials typically measure changes in hemoglobin A1c and body weight over periods of several months. The drug is administered by subcutaneous injection, and its pharmacokinetic profile supports once-weekly dosing. Post-marketing surveillance continues to evaluate long-term outcomes and rare adverse events.
Tirzepatide is a synthetic peptide that acts as a dual agonist at the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. The molecule contains 39 amino acids and features a C20 fatty diacid moiety attached via a linker, which promotes albumin binding and extends its circulating half-life. Its sequence incorporates non-natural amino acids and modifications that reduce susceptibility to degradation by dipeptidyl peptidase-4. This dual receptor activity distinguishes it from selective GLP-1 receptor agonists.
Published work supports the view that engaging two incretin receptors produces changes in glucose handling and body weight larger than those seen with single-receptor activation. Why that difference arises is not fully settled. Open questions include how much of the observed weight effect depends on central versus peripheral signaling, and whether the two receptors form interacting complexes. Most reported findings come from controlled trials and animal models, and translation between species is imperfect. Further research is expected to refine these points over time.
Tirzepatide is a synthetic peptide built from 39 amino acid residues. Its sequence is related to human glucose-dependent insulinotropic polypeptide, with modifications that include a C-terminal extension and a C20 fatty diacid joined through a linker. Those changes raise the molecule's affinity for serum albumin, which slows renal filtration and lengthens the time it stays in circulation. The free base has an average molecular mass near 4813.5 daltons. The compound is made by solid-phase peptide synthesis followed by chromatographic purification.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | Dual GIP/GLP-1 receptor agonist |
| Amino acid count | 39 | Contains non-natural residues |
| Modification | C20 fatty diacid | Attached via linker; promotes albumin binding |
| Half-life | Approximately 5 days | Supports once-weekly dosing |
| Primary route | Subcutaneous injection | Not for intravenous use |
Research-grade material circulates through suppliers that differ widely in documentation and testing practice, so a certificate of analysis is a starting point rather than proof of quality. Independent verification typically repeats chromatographic purity and mass confirmation on the received lot, and compares results against a retained reference standard. Regulatory status varies by jurisdiction, and a substance cleared as a medicine is not interchangeable with a research chemical of the same name. Open questions include how closely non-pharmaceutical lots match approved material in impurity profile and in aggregate content.
Solid tirzepatide is handled as a lyophilised, hygroscopic peptide powder that should be kept desiccated, protected from light, and stored frozen, typically at or below minus twenty degrees Celsius for long-term retention. Material left at ambient temperature for extended periods can take up moisture, which promotes aggregation and deamidation. Commercial liquid presentations are kept refrigerated between two and eight degrees Celsius and are not frozen. Reconstituted laboratory solutions are generally held cold and used within a short window because hydrolysis and oxidation continue slowly in solution.
Identity and purity are usually established with reversed-phase high-performance liquid chromatography for the main peak and with mass spectrometry for the observed molecular mass. Peptide mapping after enzymatic digestion confirms the primary sequence, while amino acid analysis provides a quantitative composition check. Size-exclusion chromatography and ion-exchange chromatography are used to look for aggregates and charge variants. Water content, residual solvents, and counter-ion content are measured separately, since a lyophilised powder is often reported on an as-is basis unless a correction is applied.
质量控制环节关注外观、含量、纯度、有关物质、水分与微生物限度等项目。检测结果需要有对照品和系统适用性数据支持，单次测定不足以判定批次的稳定性。实验室之间方法转移时，色谱柱品牌与梯度差异常导致保留时间漂移，因此方法验证十分必要。
固体状态的 tirzepatide 通常以冻干粉形式保存，推荐在低温、避光、干燥条件下存放，常见区间为 2 至 8 摄氏度，长期保存可考虑更低温度并避免反复冻融。冻融循环会导致肽链聚集或析出，从而影响后续定量结果。容器密封性与湿度控制同样是稳定性研究中反复强调的因素。
溶解操作一般使用注射用水或适宜的水性缓冲液，必要时加入少量助溶剂以改善溶解速度，但应避免剧烈涡旋振荡，因为剪切力可能促进聚集。配制后的溶液在冷藏条件下的稳定时间通常短于固体形态，具体时限取决于浓度、缓冲体系与容器材质。是否加入防腐成分，则取决于用途是否为多次取样。
The molecule is a synthetic 39-amino-acid peptide whose backbone derives from the sequence of human glucose-dependent insulinotropic polypeptide, with several substitutions that raise metabolic stability and shift receptor preference. A C20 fatty diacid is attached through a short linker to a lysine side chain, a modification that increases binding to serum albumin. The reported monoisotopic mass is approximately 4813 Da. Near neutral pH the peptide carries a net negative charge, and the lipid tail makes the molecule markedly more hydrophobic than the unmodified parent sequence.
Dual agonism at the GIP and GLP-1 receptors underlies the observed pharmacology. Activation of GLP-1 receptors raises glucose-dependent insulin release, lowers glucagon secretion, slows gastric emptying and reduces appetite. GIP receptor activation contributes additional effects on adipose tissue and on energy balance, and the combined action on appetite appears larger than either pathway alone in animal models. Signalling bias and the relative contribution of each receptor arm to weight-related effects remain areas of active investigation.
Receptor activation by tirzepatide raises intracellular cyclic AMP through Gs-coupled signalling at both targets. At the GLP-1 receptor the downstream effect includes glucose-dependent insulin release, suppressed glucagon secretion, delayed gastric emptying, and reduced appetite signalling in the hypothalamus. GIP receptor engagement adds insulinotropic activity and appears to influence lipid handling in adipose tissue. Because both receptors are stimulated at the same time, the pharmacological profile differs from that of selective GLP-1 receptor agonists, and the relative contribution of each arm remains an area of active investigation.
Clinical development proceeded through large phase 3 programmes in type 2 diabetes and in obesity or overweight with at least one weight-related comorbidity. Regulatory approvals followed in several jurisdictions for both indications. Weekly subcutaneous dosing reflects an elimination half-life of roughly five days. Open questions include the durability of metabolic effects after treatment stops, long-term cardiovascular and hepatic outcomes beyond completed trials, and whether the dual mechanism confers benefits independent of total receptor occupancy. Published literature continues to expand on these points. Substantial uncertainty remains about interindividual variability in response.
Tirzepatide is a synthetic linear peptide of 39 amino acids that acts as a dual agonist at the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. Its sequence derives from native GIP but incorporates non-natural residues and a C20 fatty diacid moiety linked to a lysine side chain. The lipophilic chain promotes albumin binding, which slows renal clearance and extends circulation time. The unmodified peptide has a molecular formula of C225H348N48O68 and a molecular mass near 4,813 daltons.
== 90Sr contamination in the environment == 90Sr is not quite as likely as 137Cs to be released as a part of a nuclear reactor accident because it is much less volatile, but is probably the most dangerous component of the radioactive fallout from a nuclear weapon. A study of hundreds of thousands of deciduous teeth, collected by Dr.Louise Reiss and her colleagues as part of the Baby Tooth Survey, found a large increase in 90Sr levels through the 1950s and early 1960s. The study's final results showed that children born in St. Louis, Missouri, in 1963 had levels of 90Sr in their deciduous teeth that was 50 times higher than that found in children born in 1950, before the advent of large-scale atomic testing. Reviewers of the study predicted that the fallout would cause increased incidence of disease in those who absorbed 90Sr into their bones. However, no follow up studies of the subjects have been performed, so the claim is untested. An article with the study's initial findings was circulated to U.S. President John F. Kennedy in 1961, and helped convince him to sign the Partial Nuclear Test Ban Treaty with the United Kingdom and Soviet Union, ending the above-ground nuclear weapons testing that placed the greatest amounts of nuclear fallout into the atmosphere. The Chernobyl disaster released roughly 10 PBq, or about 5% of the core inventory, of 90Sr into the environment. The Kyshtym disaster released 90Sr and other radioactive material into the environment. It is estimated to have released 20 MCi (800 PBq) of radioactivity.
== See also == Organic food Genetically modified food controversies JECFA Genetically modified organisms Dispute settlement in the WTO Pink slime The World According to Monsanto - a documentary about Monsanto's corporate practices
==== Sai ==== Sai appears in Demon Days: X-Men. She is an adventurous Japanese samurai accompanied by a wolf named Logan who comes from a variation of ancient Japan where humans used to coexist with yōkai until the avarice within humans caused a conflict between both species.
=== First "scientific" syntheses: aniline dyes 1858 – 1870 === In the mid 19th century, the coal tar industry, particularly in England, produced the precursors needed for a large amount of organic syntheses, in large quantities. For the first eight years after the first marketable synthetic dye, Mauveine, until the middle of the 1860s, British and French firms were the major dye producers. The second half of the 1860s saw German dye works surpassing their competition in both capacity and market share. During 1870, German firms were responsible for roughly half of the world's production of dyes and pigments. Aniline dyes were produced at scale, in part because of many advances in the synthesis of their precursors. Antoine Bechamp described a process for reducing nitrobenzene to aniline in 1854, known as the Bechamp Process, making the production of aniline easy. Widespread isolation of phenol from coal tar, made its nitration more economical, generally the path of the synthesis flowed: coal tar → nitrobenzene → aniline → dyes. According to Henry Perkin himself "This industry holds an [sic] unique position in the history of chemical industries, as it was entirely the outcome of scientific research."
At the end of his schooldays, Adorno not only benefited from the rich concert offerings of Frankfurt—where one could hear performances of works by Schoenberg, Schreker, Stravinsky, Bartók, Busoni, Delius, and Hindemith—but also began studying music composition at the Hoch Conservatory while taking private lessons with well-respected composers Bernhard Sekles and Eduard Jung. At around the same time, he befriended Siegfried Kracauer, the Frankfurter Zeitung's literary editor, of whom he would later write:
Sources: en.wikipedia.org
=== Sources === Ammirati JF, Traquair JA, Horgen PA (1985). Poisonous Mushrooms of Canada: Including other Inedible Fungi. Markham, Ontario: Fitzhenry & Whiteside in cooperation with Agriculture Canada and the Canadian Government Publishing Centre, Supply and Services Canada. ISBN 978-0-88902-977-4. Hall IR, Stephenson SL, Buchanan PK, Yun W, Cole AL (2003). Edible and Poisonous Mushrooms of the World. Portland, Oregon: Timber Press. ISBN 978-0-88192-586-9. Stuntz DE, Largent DL, Thiers HD, Johnson DJ, Watling R (1978). How to Identify Mushrooms to Genus I. Eureka, California: Mad River Press. ISBN 978-0-916422-00-4. Jaini, Padmanabh S. (1998) [1979], The Jain Path of Purification, Delhi: Motilal Banarsidass, ISBN 978-81-208-1578-0 Laidlaw, James (1995), Riches and Renunciation. Religion, economy, and society among the Jains, Oxford, ISBN 978-0198280316
At Adelaide, because of the absence of Professor Johnston, he was appointed Acting Chair of Zoology, as acting head of the department he organised the new department and its teaching. Here he was influenced by Wood Jones, Professor of Anatomy, and the physiologist Professor Brailsford Robertson, one of the pupils of Jacques Loeb. Oscar Tiegs spent three years at Adelaide, during which time he was granted a Bachelor of Science degree in 1922 and obtained his Doctorate of Science degree in 1922 both from the University of Adelaide, at the age of 25, his thesis being on the histology of metamorphosis of a pteromalid wasp (Nasonia), specifically Nasonia brevicornis (now designated Nasonia vitripennis). Oscar Tiegs' doctoral thesis work was to be the basis for much of his later work, in embryological studies, and the study of fine structures in muscle. He found clear evidence that the apparent striation of muscle fibres did not arise from separate disks, but from a helicoidal organisation within the fibre. He also found a similar condition in vertebrate muscles. Later he discovered that former histologists had recorded the same thing, but their observations had received little attention. He contended that helicoidal striation is a general feature of muscles and that muscular conduction takes place along this helicoidal path, even though the evidence for this generality was against him, yet his cinematographic records supported his interpretation for arachnids and other arthropods.
=== T-cell hypothesis === Populations of regulatory T cells are believed to be responsible for the onset of the disease. When there is a decline of these cells, manifestations of diseases begin to appear, giving an idea of the vital role of these cells in the prevention of autoimmune diseases. Moreover, an additional decrease could, unfortunately, worsen the pathological state and lead to the differentiation of an undifferentiated connective tissue disease into a differentiated connective tissue disease with a poorer prognosis. Due to the wide range of variation in the inclusion criteria of the disease, up to 50% of patients diagnosed with connective tissue disease may have undifferentiated disease of the underlying connective tissue.
Human Nutrition Unit; School of Molecular Bioscience. "Glycemic Index". International GI database. University of Sydney. – Searchable database of over 2600 foods with their glycemic index and load values. List of low GI foods Glycemic Index and Glycemic Load calculator Total values for any combinations of foods and any number of servings are computed according to FAO/WHO specifications). Diabetes UK: Glycaemic Index and Diabetes
Chromatography, including gas chromatography, GC/MS, high performance liquid chromatography, and LC/MS. Spectroscopy, including UV-Vis, CD, near infrared, and FT-IR Inductively coupled plasma, including mass spectroscopic and atomic emission spectroscopic detection. mass spectrometry, including FTMS Nuclear magnetic resonance Linear accelerator Magnetic resonance imaging X-ray Crystallography Information rich detection Drugs of Abuse Testing Dissolution Testing Vacuum Pumps Leak Detection Turbo Pumping Systems Vacuum Measurement Valves and components
Sources: en.wikipedia.org
It activates both GIP and GLP-1 receptors. This dual action differentiates it from selective GLP-1 agonists.
It is given as a subcutaneous injection. Its long half-life supports weekly dosing.
No, it is synthetic. It contains non-natural amino acids and a fatty acid modification.
It is a synthetic peptide and a dual agonist of two incretin receptors. It is not a small molecule, and it is not structurally related to the older single-receptor peptide agonists.